BofA moved to No Rating on Hologic (HOLX) following a news report that said Blackstone (BX) and TPG (TPG) are in the process of lining up $9B-$10B worth of debt financing as part of a process to acquire the company. This is the third news report in the last few months indicating interest, notes the firm, which says the reports lead it to believe a take-private deal is increasingly likely and that shares are no longer trading on fundamentals.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HOLX:
- Blackstone, TPG near deal to acquire Hologic, Bloomberg reports
- Hologic up 6% to $73.92 after Bloomberg report of potential acquisition
- Cautious Optimism: Hologic’s Envision Launch and Its Projected Financial Impact
- Hologic up 3% at $69.29 following Evercore ISI upgrade
- Hologic upgraded to Outperform from In Line at Evercore ISI